Ads
related to: lipitor pfizer astellas 5 10 25 23- Dosing & Administration
Efficacy, Safety, and Dosing
Information for HCPs
- Co-Pay Program
Resources
to Support Your Patients
- Safety
Safety Profile - Learn About
Adverse Patient Reactions
- Trial Results
See Clinical Data
and Trial
- Dosing & Administration
SCBN.org has been visited by 10K+ users in the past month
Search results
Results From The WOW.Com Content Network
Torcetrapib (CP-529,414, Pfizer) was a drug being developed to treat hypercholesterolemia (elevated cholesterol levels) and prevent cardiovascular disease.Its development was halted in 2006 when phase III studies showed excessive all-cause mortality in the treatment group receiving a combination of atorvastatin (Lipitor) and torcetrapib.
Cerivastatin (INN, [1] brand names: Baycol, Lipobay) is a synthetic member of the class of statins used to lower cholesterol and prevent cardiovascular disease.It was marketed by the pharmaceutical company Bayer A.G. in the late 1990s, competing with Pfizer's highly successful atorvastatin (Lipitor).
Pfizer (NYS: PFE) used to sell Lipitor exclusively in the United States. And it was a huge component of the company's revenue and earnings. Honest. I swear. You certainly wouldn't know it from the ...
It could have been worse. A lot worse. Sales of Pfizer's (NYS: PFE) Lipitor fell 25% in the fourth quarter after losing U.S. patent protection in November, but overall revenue fell just 4%. Being ...
Pfizer introduced Lipitor in 1997, and the drug drove more than $130 billion in sales during its first 14 years on the market. The pharma distributors claimed Pfizer fraudulently sought to extend ...
From 1996 to 2012, under the trade name Lipitor, atorvastatin became the world's best-selling medication of all time, with more than $125 billion in sales over approximately 14.5 years. [ 118 ] and $13 billion a year at its peak, [ 119 ] Lipitor alone "provided up to a quarter of Pfizer Inc.'s annual revenue for years."